How many stocks does GLENVIEW CAPITAL MANAGEMENT, LLC own?

As of Q1 2026, GLENVIEW CAPITAL MANAGEMENT, LLC holds 44 positions in their 13F portfolio.

What is GLENVIEW CAPITAL MANAGEMENT, LLC's largest holding?

CVS at 14.8% of portfolio, worth $588.7M.

What is GLENVIEW CAPITAL MANAGEMENT, LLC's total portfolio value?

$4B as of Q1 2026, tracked across 44 holdings.

Is GLENVIEW CAPITAL MANAGEMENT, LLC a hedge fund?

GLENVIEW CAPITAL MANAGEMENT, LLC is an institutional investment manager required to file SEC 13F reports. This includes hedge funds, mutual funds, pension funds, and other institutions managing over $100M.

How often does GLENVIEW CAPITAL MANAGEMENT, LLC report?

13F filings are due quarterly, approximately 45 days after each quarter end.

How has GLENVIEW CAPITAL MANAGEMENT, LLC's portfolio changed in Q1 2026?

View GLENVIEW CAPITAL MANAGEMENT, LLC's latest portfolio changes, new positions, and exits for Q1 2026 on HoldingsIntel.

What is GLENVIEW CAPITAL MANAGEMENT, LLC's investment strategy?

GLENVIEW CAPITAL MANAGEMENT, LLC is classified as a Balanced Allocator fund based on HoldingsIntel's Fund DNA analysis of 6 behavioral dimensions.

HoldingsIntel

GLENVIEW CAPITAL MANAGEMENT, L Holdings Q1 2026 - Portfolio & Conviction Scores | HoldingsIntel

GLGLENVIEW CAPITAL MANAGEMENT, LLC

Institutional investor · Portfolio as of Q1 2026

SEC EDGAR SourceSEC Filings

$4B

AUM

Positions

Q1 2026

Filing

Rating · 2.5

Quarterly Portfolio Change

Activity profile

$ moved · Q1'26

New18%Increased17%Decreased37%Exited28%

Composition

Equity vs derivatives

Equity93%Puts2%Calls5%

Holding period

Avg 2.8 years

<1Q14%1-4Q36%1-2Y2%2Y+48%

Q1 2026 Summary

Active quarter - 6 new positions, 19 exits, 17 increased. Top move: CI (INCREASED, conviction 85). Portfolio: $4.0B across 44 positions.

Portfolio Allocation

Top holdings by portfolio weight

CVS14.78%

GPN10.75%

THC7.22%

AMZN5.54%

TEVA5.04%

QQQ4.76%

CI3.34%

AMD3.32%

TMO3.09%

VTRS3.08%

Other2.81%

Position Outcomes

Best and worst performing positions by estimated return

Top Winners

THC30Q held

TENET HEALTHCARE CORP

Avg $55.91 · $214.6M est. P&L

Est. P&L

+251.77%

DOCN2Q held

DIGITALOCEAN HLDGS INC

Avg $48.80 · $26.9M est. P&L

Est. P&L

+220.88%

INTC1Q held

INTEL CORP

Avg $43.10 · $26.2M est. P&L

Est. P&L

+152.37%

Top Losers

Upgrade to Pro to see the worst-performing positions.

View plans

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Top Holdings44 positions

Export CSV(Pro)

Activity:

Stock	Shares	Value	Weight	Price Trend	Avg Buy	Est. P&L	Held	Conviction
CVS CVS HEALTH CORP	8.2M	$588.7M	14.8%	—	$58.14	+66.09%	10 qtrssince 2023-Q4	Unchanged 0
GPN GLOBAL PMTS INC	6.4M	$428.1M	10.7%	—	$107.57	-37.18%	22 qtrssince 2020-Q4	Increased 66
THC TENET HEALTHCARE CORP	1.5M	$287.8M	7.2%	—	$55.91	+251.77%	30 qtrssince 2018-Q4	Decreased 0
AMZN AMAZON COM INC	1.1M	$220.6M	5.5%	—	$194.84	+35.56%	13 qtrssince 2023-Q1	Increased 70
TEVA ADR TEVA PHARMACEUTICAL INDS LTD	6.7M	$200.6M	5.0%	—	$14.80	+131.62%	10 qtrssince 2023-Q4	Decreased 0
QQQ CALL INVESCO QQQ TR	328,200	$189.4M	4.8%	—	—	—	—	New —
CI THE CIGNA GROUP	498,841	$133.1M	3.3%	—	$264.38	+8.64%	30 qtrssince 2018-Q4	Increased 85
AMD ADVANCED MICRO DEVICES INC	650,792	$132.4M	3.3%	—	$205.72	+106.15%	2 qtrssince 2025-Q4	Increased 82
TMO THERMO FISHER SCIENTIFIC INC	250,525	$123.1M	3.1%	—	$449.53	-1.75%	4 qtrssince 2025-Q2	Increased 63
VTRS VIATRIS INC	9.1M	$122.8M	3.1%	—	$10.93	+50.83%	10 qtrssince 2023-Q4	Decreased 0
Showing 10 of 44 results.34 more with Pro.PROUpgrade to see all →